openPR Logo
Press release

Oxycodone Hydrochloride Market Size is Expected to Reach USD 675.2 Million, Advancing at a CAGR of 4.8% by 2034 | TMR Research

07-19-2024 03:07 PM CET | Health & Medicine

Press release from: Transparency Market Research

Oxycodone Hydrochloride Market

Oxycodone Hydrochloride Market

Oxycodone hydrochloride is a potent opioid analgesic used for managing moderate to severe pain. It works by binding to opioid receptors in the brain and spinal cord, altering the perception of pain. Due to its effectiveness in pain management, oxycodone hydrochloride is widely prescribed, particularly for patients with chronic pain conditions, post-surgical pain, and cancer-related pain. However, its use is also associated with risks of abuse, addiction, and regulatory scrutiny. The oxycodone hydrochloride market is influenced by these factors, as well as advancements in formulation technologies and increasing awareness about opioid misuse. This article explores the current state, trends, and future prospects of the oxycodone hydrochloride market.

Oxycodone Hydrochloride Market (산화 스트레스 분석 시장) is expected to grow at a CAGR of 4.8% from 2024 to 2034 and reach US$ 675.2 Mn by the end of 2034

Download Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86341

Overview of Oxycodone Hydrochloride Market
The global oxycodone hydrochloride market is characterized by a demand for effective pain management solutions, balanced with the need for stringent regulation to prevent misuse and addiction. The market is segmented by product type (immediate-release and extended-release formulations), route of administration (oral, injectable), application (chronic pain, acute pain, cancer pain, others), end-users (hospitals, clinics, home care settings), and geographical regions.

Market Key Players

The following companies are:

Eli Lilly and Company
Gilead Sciences, Inc.
Manus Aktteva Biopharma LLP
Arevipharma GmbH
Saneca Pharma a.s.
Cipla Ltd.
Noramco, Inc.
MacFarlan Smith
Teva Pharmaceutical Industries Ltd.
Taj Pharma
Chattem Chemicals Inc
Mayne Pharma Group Ltd.
Dr. Reddy's Laboratories Limited
Siegfried
Rhodes Pharmaceuticals L.P.
Mallinckrodt Pharmaceuticals
Johnson & Johnson
Bristol-Myers Squibb Company
Sun Pharmaceutical Industries Limited
Lupin Limited
Sanofi S.A.

Recent Developments in Oxycodone Hydrochloride Market
Recent advancements and trends in the oxycodone hydrochloride market include:

Abuse-Deterrent Formulations: Development of abuse-deterrent formulations (ADFs) to minimize the potential for misuse and addiction. These formulations make it difficult to crush, dissolve, or inject the medication.
Combination Therapies: Introduction of combination therapies that include oxycodone hydrochloride with non-opioid analgesics to enhance pain relief while reducing opioid dosage and associated risks.
Regulatory Approvals: Ongoing regulatory approvals for new formulations and generics, aimed at providing more options for pain management while ensuring patient safety.
Telehealth and Remote Prescribing: Expansion of telehealth services and remote prescribing practices, especially in response to the COVID-19 pandemic, to ensure continued access to pain management therapies.
Educational Programs: Implementation of educational programs for healthcare providers and patients to promote safe prescribing practices and raise awareness about the risks of opioid misuse.

Drivers of Market Growth
Several factors contribute to the growth of the oxycodone hydrochloride market:

Increasing Prevalence of Chronic Pain: Rising incidence of chronic pain conditions, such as arthritis, back pain, and neuropathic pain, driving the demand for effective pain management solutions.
Aging Population: Growing elderly population, which is more susceptible to chronic pain and requires long-term pain management.
Post-Surgical Pain Management: High demand for oxycodone hydrochloride in managing post-surgical pain, contributing to its widespread use in hospitals and clinics.
Cancer Pain Management: Significant use of oxycodone hydrochloride for managing cancer-related pain, enhancing quality of life for patients with advanced-stage cancer.
Technological Advancements: Continuous innovations in formulation technologies, including abuse-deterrent formulations and extended-release formulations, improving safety and efficacy.

Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86341

Conclusion
The oxycodone hydrochloride market is poised for growth, driven by the increasing prevalence of chronic pain, an aging population, demand for post-surgical and cancer pain management, and technological advancements in formulation. Innovations in abuse-deterrent formulations, combination therapies, regulatory approvals, telehealth, and educational programs are enhancing the safety and accessibility of oxycodone hydrochloride.

Market Segmentation

Type
Controlled-Release
Immediate-Release

Route of Administration
Oral
Parenteral

Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86341<ype=S

More Trending Report by Transparency Market Research:

Cardiac Pacemakers Market (Marché des stimulateurs cardiaques): https://www.globenewswire.com/en/news-release/2024/02/27/2836055/32656/en/Cardiac-Pacemakers-Market-to-Expand-at-a-3-5-CAGR-to-Attain-a-USD-5-9-billion-Valuation-by-2031-Transparency-Market-Research-Inc.html

Elderly and Disabled Assistive Devices Market (高齢者・障害者向け補助器具市場): https://www.globenewswire.com/news-release/2024/01/12/2808596/32656/en/Elderly-and-Disabled-Assistive-Devices-Market-Revenue-to-Cross-USD-31-6-billion-by-2028-Transparency-Market-Research-Inc.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oxycodone Hydrochloride Market Size is Expected to Reach USD 675.2 Million, Advancing at a CAGR of 4.8% by 2034 | TMR Research here

News-ID: 3590506 • Views:

More Releases from Transparency Market Research

RSV Vaccine Market Size Forecast to USD 15.9 Billion by 2035 with Rising Focus on Infectious Disease Prevention - Analysis by Transparency Market Research
RSV Vaccine Market Size Forecast to USD 15.9 Billion by 2035 with Rising Focus o …
Respiratory Syncytial Virus Vaccine Market Outlook 2035 The global respiratory syncytial virus (RSV) vaccine market was valued at US$ 3.7 Bn in 2024 and is projected to cross US$ 15.9 Bn by the end of 2035, expanding at a CAGR of 13.8% from 2025 to 2035. The market is witnessing rapid growth driven by increasing awareness of RSV infections, rising immunization programs, and strong pipeline developments by leading pharmaceutical companies. 👉 Get
Otoscopes Market Outlook 2035: Digital Innovation, Rising Ear Disorder Cases, and AI Integration to Drive Growth Beyond USD 278.5 Million
Otoscopes Market Outlook 2035: Digital Innovation, Rising Ear Disorder Cases, an …
The global otoscopes market was valued at US$ 184.2 Mn in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 3.9% from 2025 to 2035, reaching more than US$ 278.5 Mn by the end of 2035. This steady growth trajectory reflects the increasing demand for advanced diagnostic tools, rising awareness of ear health, and continuous technological advancements in medical devices. The market's moderate yet consistent expansion
Wire & Cable Plastics Market to Reach USD 21.1 Billion by 2036 - Expanding at 4.1% CAGR | By Material / By Voltage Range | India • China • U.S. • Germany
Wire & Cable Plastics Market to Reach USD 21.1 Billion by 2036 - Expanding at 4. …
The global Wire & Cable Plastics Market was valued at USD 13.6 Billion in 2025 and is projected to reach USD 21.1 Billion by 2036, growing at a compound annual growth rate (CAGR) of 4.1% from 2026 to 2036. Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=65801 This steady growth reflects the increasing importance of advanced polymer compounds in electrical infrastructure, telecommunications, renewable energy systems, and emerging digital
Large Blow Molded Products Market to Reach USD 9.7 Billion by 2036 Driven by Rising Demand for Durable Plastic Solutions
Large Blow Molded Products Market to Reach USD 9.7 Billion by 2036 Driven by Ris …
The global large blow molded products market is witnessing steady growth, driven by increasing demand for lightweight, durable, and cost-effective plastic products across various industries. The market size was valued at USD 5.9 Billion in 2025 and is projected to reach USD 9.7 Billion by 2036, expanding at a CAGR of 4.6% from 2026 to 2036. Growing applications in packaging, automotive, construction, and industrial sectors are significantly contributing to market

All 5 Releases


More Releases for Pharma

Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the